Yvonne Greenstreet sold $4.0M of Alnylam Pharmaceuticals (ALNY)

Executed Oct 2 2025, disclosed Oct 3 2025, 1 day later.

Value, as filed

$4.0M

8,744 sh across 10 lots

Executed

Oct 2 2025

the trade date, as filed

Disclosed

Oct 3 2025

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Yvonne Greenstreet Chief Executive Officer profile →

Yvonne Greenstreet (Chief Executive Officer) filed 6 Form 4 reports in the trailing twelve months (0 purchases, 6 sales), most often in Alnylam Pharmaceuticals, Inc. (ALNY). The largest single filing was $11.5M of ALNY (25,455 sh across 19 lots, as filed), executed Nov 12 2025.

The name

ALNY

Alnylam Pharmaceuticals, Inc. ALNY · Healthcare · 56 filings in 24 months ticker →

Healthcare · Alnylam Pharmaceuticals, Inc. discovers, develops, manufactures, and commercializes therapeutics based on ribonucleic acid interference in…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Yvonne Greenstreet in ALNY

ALNYSALE Alnylam Pharmaceuticals, Inc. $689K
2,130 sh across 4 lots
Exec Mar 4
Filed Mar 6 · 5:30 PM ET ALNYSALE Alnylam Pharmaceuticals, Inc. $2.1M
6,439 sh across 8 lots
Exec Mar 2
Filed Mar 4 · 5:30 PM ET ALNYSALE Alnylam Pharmaceuticals, Inc. $2.2M
6,958 sh × $310.08
Exec Feb 13
Filed Feb 17 · 5:30 PM ET ALNYSALE Alnylam Pharmaceuticals, Inc. $2.8M
7,845 sh across 11 lots
Exec Jan 12
Filed Jan 14 · 5:30 PM ET ALNYSALE Alnylam Pharmaceuticals, Inc. $11.5M
25,455 sh across 19 lots
Exec Nov 12 2025
Filed Nov 14 2025 · 5:30 PM ET ALNYSALE Alnylam Pharmaceuticals, Inc. $3.0M
6,530 sh across 5 lots
Exec Aug 18 2025
Filed Aug 19 2025 · 5:30 PM ET ALNYSALE Alnylam Pharmaceuticals, Inc. $15.5M
50,937 sh across 3 lots
Exec May 30 2025
Filed Jun 3 2025 · 5:30 PM ET ALNYSALE Alnylam Pharmaceuticals, Inc. $880K
3,612 sh across 4 lots
Exec Mar 3 2025
Filed Mar 5 2025 · 5:30 PM ET